newsIDegLira demonstrates superior glycaemic control and weight loss with a low rate of hypoglycaemia for patients uncontrolled on basal insulinNew phase 3 data from the investigational therapy IDegLira were…3 December 2013 | By Novo NordiskNew phase 3 data from the investigational therapy IDegLira were presented at the World Diabetes Congress of the International Diabetes Federation...
newsNew epidemiological data provide additional safety evidence for Lantus®New results of a large-scale epidemiological program announced...11 June 2012 | By SanofiNew results of a large-scale epidemiological program announced...
newsBYETTA® approved for use with insulin glargine in the U.S.FDA has approved a new use for BYETTA® (exenatide) injection....19 October 2011 | By Eli Lilly and CompanyFDA has approved a new use for BYETTA® (exenatide) injection....
